Patent · US Active

C3B binding polypeptide

US12383600B2 · kind B2 · utility

0Cited by

6References

20Claims

0Family size

Assignee

Complement Therapeutics Limited · GB

Inventors

Paul D. Bishop · Fall City, US
Simon Clark · San Mateo, US
Richard Unwin · London, GB

Key dates

Filing date	Nov 4, 2022
Grant date	Aug 12, 2025
Priority date	—
Expiry date	Nov 4, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed are uses and methods using the polypeptides for treating and preventing diseases and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.